Preservation of midbrain catecholaminergic neurons in very old human subjects

被引:110
作者
Kubis, N
Faucheux, BA
Ransmayr, G
Damier, P
Duyckaerts, C
Henin, D
Forette, B
Le Charpentier, Y
Hauw, JJ
Agid, Y
Hirsch, EC
机构
[1] Hop La Pitie Salpetriere, INSERM U289, F-75013 Paris, France
[2] Hop La Pitie Salpetriere, Lab Neuropathol R Escourolle, INSERM U360, F-75013 Paris, France
[3] Hop Bichat Claude Bernard, Serv Anatomopathol, F-75877 Paris, France
[4] Hop St Perrine, Serv Geriatr, Paris, France
[5] Hop Pitie, Serv Anatomopathol, F-75651 Paris, France
[6] Univ Innsbruck, Neurol Klin, A-6020 Innsbruck, Austria
关键词
substantia nigra; tyrosine hydroxylase; ageing; human;
D O I
10.1093/brain/123.2.366
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Parkinson's disease is characterized by a progressive degeneration of dopaminergic neurons in the midbrain, yet the cause of this neuronal loss is still unknown. It has been hypothesized that Parkinson's disease could be the consequence of accelerated ageing. In order to reveal a possible common process during ageing and Parkinson's disease neurodegeneration, catecholaminergic neurons of five anatomical regions of the brainstem (substantia nigra, central grey substance, ventral tegmental area, peri-and retrorubral area, and locus coeruleus) have been quantified using immunohistochemical staining for tyrosine hydroxylase (TH) on regularly spaced sections, between the rostral and caudal poles of the mesencephalon and in the rostral pole of the pens, in post-mortem samples of 21 control subjects who died at ages 44-110 years. No statistically significant loss of TH positive neurons was observed in the older subjects, either in the substantia nigra or in the other midbrain regions that are known to degenerate to a lesser degree in Parkinson's disease. Furthermore, in the later regions no neuronal loss was observed from age 44 to 80 years, indicating that this result is not dependent on the inclusion of 'supernormal' very old people. These results suggest that from age 44 to 110 years, ageing in control adults is not, or is scarcely, accompanied by catecholaminergic cell loss in the midbrain and hence Parkinson's disease is probably not caused by an acceleration of a degenerative process during ageing.
引用
收藏
页码:366 / 373
页数:8
相关论文
共 34 条
[1]   ESTIMATION OF NUCLEAR POPULATION FROM MICROTOME SECTIONS [J].
ABERCROMBIE, M .
ANATOMICAL RECORD, 1946, 94 (02) :239-247
[2]   DIFFERING PATTERNS OF STRIATAL F-18 DOPA UPTAKE IN PARKINSONS-DISEASE, MULTIPLE SYSTEM ATROPHY, AND PROGRESSIVE SUPRANUCLEAR PALSY [J].
BROOKS, DJ ;
IBANEZ, V ;
SAWLE, GV ;
QUINN, N ;
LEES, AJ ;
MATHIAS, CJ ;
BANNISTER, R ;
MARSDEN, CD ;
FRACKOWIAK, RSJ .
ANNALS OF NEUROLOGY, 1990, 28 (04) :547-555
[3]   AGING OF THE NIGROSTRIATAL PATHWAY IN HUMANS [J].
CALNE, DB ;
PEPPARD, RF .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1987, 14 (03) :424-427
[4]  
CAREY JR, 1992, SCIENCE, V258, P457, DOI 10.1126/science.1411540
[5]   QUANTITATION OF CATECHOLAMINE NEURONS IN THE LOCUS COERULEUS IN HUMAN BRAINS OF NORMAL YOUNG AND OLDER ADULTS AND IN DEPRESSION [J].
CHANPALAY, V ;
ASAN, E .
JOURNAL OF COMPARATIVE NEUROLOGY, 1989, 287 (03) :357-372
[7]  
COWELL PE, 1994, J NEUROSCI, V14, P4748
[8]   DEMOGRAPHY OF GENOTYPES - FAILURE OF THE LIMITED LIFE-SPAN PARADIGM IN DROSOPHILA-MELANOGASTER [J].
CURTSINGER, JW ;
FUKUI, HH ;
TOWNSEND, DR ;
VAUPEL, JW .
SCIENCE, 1992, 258 (5081) :461-463
[9]   AGE-RELATED-CHANGES IN THE HUMAN NIGROSTRIATAL DOPAMINERGIC SYSTEM [J].
DEKEYSER, J ;
EBINGER, G ;
VAUQUELIN, G .
ANNALS OF NEUROLOGY, 1990, 27 (02) :157-161
[10]  
DORAISWAMY PM, 1992, AM J NEURORADIOL, V13, P383